Analyst Activity – Argus Initiates Coverage On NASDAQ:TECH – BIO-TECHNE (NASDAQ:TECH) With a Buy

Analyst Ratings For NASDAQ:TECH – BIO-TECHNE (NASDAQ:TECH)

Story continues below

Today, Argus initiated coverage on NASDAQ:TECH – BIO-TECHNE (NASDAQ:TECH) with a Buy with a price target of $185.00.

Some recent analyst ratings include

  • 6/15/2018-Argus initiated coverage with a Buy rating.
  • 2/7/2018-Craig Hallum Reiterated Rating of Buy.
  • 10/24/2017-Citigroup Reiterated Rating of Buy.
  • 7/13/2017-Wells Fargo & Co initiated coverage with a Market Perform ➝ Market Perform rating.

Dividend information for NASDAQ:TECH – BIO-TECHNE (NASDAQ:TECH)

NASDAQ:TECH – BIO-TECHNE (NASDAQ:TECH) pays an annual dividend of $1.28 with a yield of 0.78%.

Dividend History for NASDAQ:TECH – BIO-TECHNE (NASDAQ:TECH)

  • On 5/3/2018 NASDAQ:TECH – BIO-TECHNE announced a quarterly dividend of $0.32 0.87% with an ex dividend date of 5/11/2018 which will be payable on 5/25/2018.
  • On 2/7/2018 NASDAQ:TECH – BIO-TECHNE announced a quarterly dividend of $0.32 0.94% with an ex dividend date of 2/15/2018 which will be payable on 3/2/2018.
  • On 10/31/2017 NASDAQ:TECH – BIO-TECHNE announced a Quarterly dividend of $0.32 1% with an ex dividend date of 11/9/2017 which will be payable on 11/24/2017.
  • On 8/9/2017 NASDAQ:TECH – BIO-TECHNE announced a Quarterly dividend of $0.32 1.1% with an ex dividend date of 8/16/2017 which will be payable on 9/1/2017.
  • On 5/2/2017 NASDAQ:TECH – BIO-TECHNE announced a quarterly dividend of $0.32 1.15% with an ex dividend date of 5/17/2017 which will be payable on 6/2/2017.
  • On 2/7/2017 NASDAQ:TECH – BIO-TECHNE announced a quarterly dividend of $0.32 1.27% with an ex dividend date of 2/15/2017 which will be payable on 3/3/2017.
  • On 11/1/2016 NASDAQ:TECH – BIO-TECHNE announced a Quarterly dividend of $0.32 with an ex dividend date of 11/9/2016 which will be payable on 11/28/2016.

Recent Insider Trading Activity For NASDAQ:TECH – BIO-TECHNE (NASDAQ:TECH)
NASDAQ:TECH – BIO-TECHNE (NASDAQ:TECH) has insider ownership of 3.40% and institutional ownership of 94.60%.

  • On 6/7/2018 Charles R Kummeth, CEO, sold 8,000 with an average share price of $160.00 per share and the total transaction amounting to $1,280,000.00.
  • On 2/13/2018 Charles A Dinarello, Director, sold 5,000 with an average share price of $136.06 per share and the total transaction amounting to $680,300.00.
  • On 11/1/2017 Robert V Baumgartner, Director, sold 5,000 with an average share price of $130.18 per share and the total transaction amounting to $650,900.00.
  • On 10/10/2017 Roger C Lucas, Director, sold 100 with an average share price of $121.96 per share and the total transaction amounting to $12,196.00.
  • On 9/8/2017 Roger C Lucas, Director, sold 100 with an average share price of $120.94 per share and the total transaction amounting to $12,094.00.
  • On 9/6/2017 Karen A Holbrook, Director, sold 1,059 with an average share price of $121.73 per share and the total transaction amounting to $128,912.07.
  • On 8/10/2017 Roger C Lucas, Director, sold 100 with an average share price of $114.30 per share and the total transaction amounting to $11,430.00.

Recent Trading Activity for NASDAQ:TECH – BIO-TECHNE (NASDAQ:TECH)
Shares of NASDAQ:TECH – BIO-TECHNE closed the previous trading session at 164.51 up +0.45 0.27% with 166.47000122070312 shares trading hands.

An ad to help with our costs